KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) FCF Margin (2016 - 2025)

Pfizer (PFE) has disclosed FCF Margin for 17 consecutive years, with 14.11% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin rose 2960.0% to 14.11% in Q4 2025 year-over-year; TTM through Dec 2025 was 14.5%, a 6346.0% increase, with the full-year FY2025 number at 14.5%, down 10275.0% from a year prior.
  • FCF Margin was 14.11% for Q4 2025 at Pfizer, down from 174.11% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1371.72% in Q3 2024 to a low of 116.98% in Q2 2024.
  • A 5-year average of 102.06% and a median of 21.3% in 2022 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: skyrocketed 135211bps in 2024, then tumbled -119761bps in 2025.
  • Pfizer's FCF Margin stood at 103.58% in 2021, then fell by -21bps to 81.5% in 2022, then surged by 50bps to 122.19% in 2023, then plummeted by -113bps to 15.49% in 2024, then soared by 191bps to 14.11% in 2025.
  • Per Business Quant, the three most recent readings for PFE's FCF Margin are 14.11% (Q4 2025), 174.11% (Q3 2025), and 8.19% (Q2 2025).